Mononit Retard 50

Mononit Retard 50 Brand names, Mononit Retard 50 Analogs

Mononit Retard 50 Brand Names Mixture

No information avaliable

Mononit Retard 50 Chemical_Formula

C₆H₉NO₆

Mononit Retard 50 RX_link

http://www.rxlist.com/cgi/generic/isomono2.htm

Mononit Retard 50 fda sheet

http://www.fda.gov/cder/foi/anda/98/75-147_Isosorbide.htm

Mononit Retard 50 msds (material safety sheet)

Mononit_Retard_50 MSDS

Mononit Retard 50 Synthesis Reference

Hayward et al., Can.J.Chem., 45; 2191-2192 (1967)

Mononit Retard 50 Molecular Weight

191.139 g/mol

Mononit Retard 50 Melting Point

88-91^oC

Mononit Retard 50 H₂O Solubility

1.07E+005 mg/L

Mononit Retard 50 State

Solid

Mononit Retard 50 LogP

-0.15

Mononit Retard 50 Dosage Forms

Tablet (immediate release); Tablet (extended release)

Mononit Retard 50 Indication

For the prevention of angina pectoris due to coronary artery disease and the treatment of acute and chronic angina pectoris, hypertension, and myocardial infarction.

Mononit Retard 50 Pharmacology

Isosorbide-5-mononitrate, the long-acting metabolite of isosorbide dinitrate, is used as a vasodilatory agent in the management of angina pectoris. By dilating the vessels, it lowers the blood pressure and reduces the left ventricular preload and afterload, therefore, leads to a reduction of myocardial oxygen requirement.

Mononit Retard 50 Absorption

100%

Mononit Retard 50 side effects and Toxicity

Symptoms of overdose include vasodilatation, venous pooling, reduced cardiac output, and hypotension. LD₅₀=mg/kg(orally in rat)

Mononit Retard 50 Patient Information

Mononit Retard 50 Organisms Affected

Humans and other mammals